5:34 PM
 | 
Aug 10, 2009
 |  BC Extra  |  Company News

Forest licenses U.S. rights to Daxas

Nycomed Group A/S (Zurich, Switzerland) granted Forest Laboratories Inc. (NYSE:FRX) exclusive, U.S. rights to Daxas roflumilast....

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >